{"entity":{"id":"idea-crc-exercise-as-a-funded-treatment","kind":"idea","name":"Fund structured exercise after colon cancer surgery as a treatment, because a randomised trial says it works as well as a drug","aka":[],"tldr":"A three-year supervised exercise programme after chemotherapy cut recurrence and death by roughly a third in 889 patients, an effect the size of adjuvant chemotherapy. No health system has a funding line for it.","summary":"CHALLENGE randomised 889 patients with resected colon cancer who had completed adjuvant chemotherapy to a structured exercise programme or health-education materials over three years. At a median 7.9 years, disease-free survival favoured exercise with a hazard ratio of 0.72 (five-year disease-free survival 80.3 against 73.9 percent), and overall survival with a hazard ratio of 0.63 (eight-year overall survival 90.3 against 83.2 percent). Musculoskeletal adverse events were more common with exercise (18.5 against 11.5 percent).\n\nThe trial took 15 years to enrol because no commercial sponsor benefits from the result, and the intervention is a supervised programme with a behaviour-support consultant rather than advice to be more active. That is the gap: the evidence is now stronger than for several funded drugs in the same setting, and the implementation question, who employs the trainers and how patients are referred, has never been tested in a health system.","asOf":"2026-09-24","links":[{"label":"Ligibel et al., Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline (J Clin Oncol 2022)","url":"https://doi.org/10.1200/JCO.22.00687"},{"label":"Ramsey et al., Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners (Support Care Cancer 2022)","url":"https://doi.org/10.1007/s00520-022-07342-6"},{"label":"Courneya et al.: CHALLENGE (N Engl J Med 2025)","url":"https://europepmc.org/article/MED/40450658"}],"tags":["colorectal-evidence","protocol-upgrade","upgrade:proven-unevenly-used","evidence:strong"],"related":["idea-exercise-as-adjuvant","rejuv-access-exercise-programmes","colorectal-roadmap","survivorship-roadmap","nutrition-lifestyle-roadmap"],"cancers":["colorectal","colon-cancer"],"sections":["supportive-care","nutrition-lifestyle","rejuvenation"],"technologies":["structured-exercise-survivorship","exercise-prescription-after-cancer","exercise-oncology"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-survivorship","b-funding-allocation","b-prevention-adoption","b-incentive-misalignment"],"keyPapers":["paper-challenge-exercise-nejm-2025"],"journals":[],"dependsOn":[],"notes":["Protocol upgrade, graded proven but unevenly used. Beyond CHALLENGE, the 2022 ASCO guideline states that oncology providers should recommend regular aerobic and resistance exercise during active treatment with curative intent. No audit OnCo found measures how many patients are referred to a structured programme; in an international survey of 375 practitioners in cancer care in 2020 and 2021, 35 to 50 per cent reported poor knowledge of when, how and which survivors to refer to exercise programmes (Ramsey, 2022)."],"hypothesis":"A funded, referral-based structured exercise service for patients completing adjuvant chemotherapy for colon cancer reproduces at least half of the CHALLENGE disease-free survival effect in routine practice, at a cost per quality-adjusted life year below the threshold used for adjuvant drugs in the same indication.","rationale":"The randomised effect size is comparable to adjuvant chemotherapy at a fraction of the drug cost and with reversible musculoskeletal rather than neurological harm; the only untested step is whether a health service can deliver the programme as the trial did.","test":"A stepped-wedge implementation trial across cancer centres, with adherence to the exercise prescription and three-year disease-free survival as co-primary endpoints, a pre-registered health-economic analysis, and equity of referral and completion by deprivation quintile as a reported outcome.","maturity":"early-clinical","actor":"payer","cost":"medium","horizonYears":4},"route":"/ideas/idea-crc-exercise-as-a-funded-treatment/","neighbours":{"idea":[{"id":"idea-exercise-as-adjuvant","kind":"idea","name":"Structured exercise prescribed like a drug in all curative-intent cancer care","route":"/ideas/idea-exercise-as-adjuvant/"}],"technology":[{"id":"exercise-oncology","kind":"technology","name":"Exercise & lifestyle oncology","route":"/technologies/exercise-oncology/"},{"id":"rejuv-access-exercise-programmes","kind":"technology","name":"Exercise is the best-evidenced thing on this front, and most survivors are not doing it","route":"/technologies/rejuv-access-exercise-programmes/"},{"id":"structured-exercise-survivorship","kind":"technology","name":"Structured exercise programmes after curative treatment","route":"/technologies/structured-exercise-survivorship/"},{"id":"exercise-prescription-after-cancer","kind":"technology","name":"The exercise prescription after cancer: the dose the guidelines state","route":"/technologies/exercise-prescription-after-cancer/"}],"roadmap":[{"id":"colorectal-roadmap","kind":"roadmap","name":"Colorectal cancer roadmap: from the adenoma-carcinoma sequence and the first screening trials to total mesorectal excision, oxaliplatin, RAS testing, immunotherapy for mismatch repair-deficient disease, ctDNA-guided treatment and organ preservation","route":"/roadmaps/colorectal-roadmap/"},{"id":"nutrition-lifestyle-roadmap","kind":"roadmap","name":"Diet, exercise and lifestyle roadmap: causes established → interventions that disappointed → exercise proven as treatment","route":"/roadmaps/nutrition-lifestyle-roadmap/"},{"id":"survivorship-roadmap","kind":"roadmap","name":"Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards","route":"/roadmaps/survivorship-roadmap/"}],"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"section":[{"id":"nutrition-lifestyle","kind":"section","name":"Diet, Exercise & Lifestyle","route":"/fronts/nutrition-lifestyle/"},{"id":"rejuvenation","kind":"section","name":"Recovery & Rejuvenation","route":"/fronts/rejuvenation/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"bottleneck":[{"id":"b-funding-allocation","kind":"bottleneck","name":"Funding follows fashion, not burden","route":"/bottlenecks/b-funding-allocation/"},{"id":"b-incentive-misalignment","kind":"bottleneck","name":"Incentives reward me-too drugs and marginal gains","route":"/bottlenecks/b-incentive-misalignment/"},{"id":"b-prevention-adoption","kind":"bottleneck","name":"Prevention we already have is not deployed","route":"/bottlenecks/b-prevention-adoption/"},{"id":"b-survivorship","kind":"bottleneck","name":"Survivorship and late effects are neglected","route":"/bottlenecks/b-survivorship/"}],"paper":[{"id":"paper-challenge-exercise-nejm-2025","kind":"paper","name":"CHALLENGE: a structured exercise programme after chemotherapy improves survival in colon cancer","route":"/key-papers/paper-challenge-exercise-nejm-2025/"}]}}